Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorConsorci Sanitari Integral

About this trial

This is a multicenter, prospective, interventional clinical trial designed to evaluate and compare two intraoperative imaging modalities: laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG), for the identification of biliary anatomy in technically challenging laparoscopic cholecystectomy. All enrolled subjects will undergo both LUS and ICG during the index procedure, following a standardized sequence, in order to allow intra-subject comparison. LUS will be performed first, followed by fluorescence cholangiography prior to Calot's triangle dissection.

The primary endpoint is the successful identification of the critical junction. Secondary endpoints include visualization of individual biliary structures, time to visualization, total operative time, intraoperative and postoperative complications.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years.

Written informed consent provided.

Acute cholecystitis.

Previous cholangitis, pancreatitis, or endoscopic retrograde cholangiopancreatography.

Disqualifiers

Known allergy to ICG or iodine.

Pregnancy or breastfeeding.

High risk of choledocholithiasis (ESGE guidelines).

Thyroid disease.

Trial design

Design model

Single group

Treatments tested in this trial

  • Laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG)

    Diagnostic test

    Two intraoperative imaging modalities will be applied: laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG), for the identification of biliary anatomy in technically challenging laparoscopic cholecystectomy. All enrolled subjects will undergo both LUS and ICG during the index procedure, following a standardized sequence, in order to allow intra-subject comparison. LUS will be performed first, followed by fluorescence cholangiography prior to Calot's triangle dissection.

Treatment groups

62 Participants
are divided into 1 treatment group
Group A: Complex laparoscopic cholecystectomyOther 1 intervention

Trial outcomes

Primary outcomes

1

Clear intraoperative identification of the junction between the cystic duct, the common hepatic duct, and the common bile duct

This intraoperative visualization will be assessed separately for laparoscopic ultrasound (LUS) and indocyanine green fluorescence cholangiography (ICG) and recorded as a binary outcome (yes/no) for each technique in each patient using a standardized intraoperative assessment form completed by the operating surgeon. Laparoscopic ultrasound will be performed first, followed by indocyanine green fluorescence cholangiography, according to a predefined and standardized intraoperative sequence. Intraoperative photographic documentation will be obtained for each imaging modality to objectively demonstrate the visualization of the critical biliary junction. Results will be reported as the proportion of patients with successful visualization for each modality and compared using an intra-subject analysis.

Time frame
Intraoperative

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Consorci Sanitari Integral

Lead sponsor

Hospital Moisés Broggi de Sant Joan Despí, Barcelona

Collaborator

Hospital Clínico Universitario de Valencia

Collaborator

Hospital Germans Tríes i Pujol de Badalona

Collaborator

Hospital Joan XXIII, Tarragona

Collaborator

Consorcio Parc de Salut Mar, Hospital del Mar

Collaborator

Hospital Mutua de Terrassa

Collaborator